(Q35881786)

10 August 2017

Genetic influences on cognitive decline in Parkinson's disease (English)

1 reference

10 August 2017

1 reference

9

Daniel Weintraub

1 reference

10 August 2017

13

Andrew Siderowf

1 reference

10 August 2017

7

Nabila Dahodwala

1 reference

10 August 2017

4

Matthew B Stern

1 reference

10 August 2017

3

Howard I Hurtig

1 reference

10 August 2017

5

Amy Colcher

1 reference

10 August 2017

10

Alice S Chen-Plotkin

1 reference

10 August 2017

James F Morley

1

1 reference

10 August 2017

Sharon X Xie

2

1 reference

10 August 2017

Stacy Horn

6

1 reference

10 August 2017

John E Duda

8

1 reference

10 August 2017

Vivianna Van Deerlin

11

1 reference

10 August 2017

Dana Falcone

12

1 reference

10 August 2017

language of work or name

English

0 references

publication date

16 February 2012

1 reference

10 August 2017

1 reference

10 August 2017

27

1 reference

10 August 2017

512-518

1 reference

10 August 2017

4

1 reference

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Robust and expanded norms for the Dementia Rating Scale

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

The association of APOE genotype and cognitive decline in interaction with risk factors in a 65-69 year old community sample

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

A systematic review of prevalence studies of dementia in Parkinson's disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Random-effects models for longitudinal data

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Parkinsonism: onset, progression, and mortality

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Apolipoprotein E epsilon 4 allele is not associated with age at onset or MMSE of Parkinson's disease in a Korean study.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Phenotypic associations of tau and ApoE in Parkinson's disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Apolipoprotein E and dementia in Parkinson disease: a meta-analysis.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

The rate of cognitive decline in Parkinson disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Risk of dementia in Parkinson's disease: a community-based, prospective study.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Validity of the Dementia Rating Scale in assessing cognitive function in Parkinson's disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

Antecedent clinical features associated with dementia in Parkinson's disease

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323737

APOE and the risk of PD with or without dementia in a population-based study

24 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FMDS.24946

The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia

21 January 2018

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

Lack of association of APOE and tau polymorphisms with dementia in Parkinson's disease

1 reference

PubMed

12 December 2020

Identifiers

DOI

10.1002/MDS.24946

1 reference

10 August 2017

1 reference

10 August 2017

1 reference